San Francisco, California, Decmber 05, 2018: A report by TMR Research, titled, “Ursodeoxycholic Acid Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018–2028,” presents useful information on the market. At the outset, the report states that ursodeoxycholic acid (UDCA) is mainly bile acid taken either in the form of tablets or liquid. Those can cure gallstones. They can also prevent progress of cystic fibrosis-related liver disorders.
Mainly fuelling demand in the global ursodeoxycholic acid market is the cholestatic liver diseases. Growing occurrence of cystic fibrosis and gall stones is primarily driving demand in the market. The report finds that women are more susceptible to gallstones than men. This is due to the higher levels of estrogens resulting from pregnancy, birth control pills, and hormone replacement therapy.
Get Sample Copy of this Report @
In addition, older adults are prone to gallstones too alongside those with a family history of gallstones. Mainly surgery is carried out for such conditions. However, ursodeoxycholic acid is emerging as a viable option too. Those can dissolve smaller stones of cholesterol. Hence, the global ursodeoxycholic acid market is poised to rise in the near term.
One factor hampering the global ursodeoxycholic acid market is the side effects of UDCA. The treatment frequently causes diarrhea. Other side effects include nausea, vomiting, dry skin or itching, headache, and sleep disturbance. Owing to such side effects, ursodeoxycholic acid is not fit during the first trimester of pregnancy.
Based on type, the global ursodeoxycholic acid market can be bifurcated into synthetic ursodeoxycholic acid and extraction ursodeoxycholic acid. Currently, the synthetic ursodeoxycholic acid is highly sought after. With respect to usage, the market can be segmented into pharmacy and health products. At present, the health products are generating most of the demand in the market.
Read Comprehensive Overview of Report @
Key players in the global ursodeoxycholic acid market are Arcelor Chemicals, Biotavia Labs, Abil Chempharma, Dipharma Francis, and Daewoong Chemical.